Literature DB >> 19038006

Intraductal carcinoma component as a favorable prognostic factor in biliary tract carcinoma.

Hidenori Ojima1, Yae Kanai, Motoki Iwasaki, Nobuyoshi Hiraoka, Kazuaki Shimada, Tsuyoshi Sano, Yoshihiro Sakamoto, Minoru Esaki, Tomoo Kosuge, Michiie Sakamoto, Setsuo Hirohashi.   

Abstract

The aim of this study is to evaluate the prognostic impact of an intraductal carcinoma component and bile duct resection margin status in patients with biliary tract carcinoma. An intraductal carcinoma component was defined as carcinoma within the bile duct outside the main tumor nodule consisting of a subepithelial invasive component. Surgically resected materials from 214 patients were evaluated by histological observations. Seventy-nine patients (36.9%) with an intraductal carcinoma component infrequently developed large tumors and infrequently showed deep invasion and venous, lymphatic and perineural involvement in the main tumor nodule. An intraductal carcinoma component was inversely correlated with advanced clinical stage, and was shown to be a significantly favorable prognostic factor by both univariate and multivariate analyses. Proximal (hepatic) side bile duct resection margin status was categorized into negative for tumor cells, positive with only an intraductal carcinoma component [R1 (is)], and positive with a subepithelial invasive component (R1). Forty-five patients (21.0%) with an R1 resection margin had a poorer prognosis than 148 patients (69.2%) with a negative resection margin, whereas 21 patients (9.8%) with an R1 (is) resection margin did not. In patients with an R1 resection margin, the risk of anastomotic recurrence was higher, and the period until anastomotic recurrence was shorter, than in patients with an R1 (is) resection margin. Surgeons should not be persistent in trying to achieve a negative surgical margin when the intraoperative frozen section diagnosis is R1 (is), and can choose a safe surgical procedure to avoid postoperative complications.

Entities:  

Mesh:

Year:  2008        PMID: 19038006     DOI: 10.1111/j.1349-7006.2008.01009.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  10 in total

1.  Isolated caudate lobectomy with pancreatoduodenectomy for a bile duct cancer.

Authors:  Tsuyoshi Sano; Yasuhiro Shimizu; Yoshiki Senda; Koji Komori; Seiji Ito; Tetsuya Abe; Taira Kinoshita; Yuji Nimura
Journal:  Langenbecks Arch Surg       Date:  2013-09-13       Impact factor: 3.445

Review 2.  Association between Helicobacter spp. infections and hepatobiliary malignancies: a review.

Authors:  Fany Karina Segura-López; Alfredo Güitrón-Cantú; Javier Torres
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

3.  Evaluation of positive ductal margins of biliary tract cancer in intraoperative histological examination.

Authors:  Junji Ueda; Hiroshi Yoshida; Yasuhiro Mamada; Nobuhiko Taniai; Masato Yoshioka; Atsushi Hirakata; Youichi Kawano; Yoshiaki Mizuguchi; Tetsuya Shimizu; Tomohiro Kanda; Hideyuki Takata; Ryota Kondo; Eiji Uchida
Journal:  Oncol Lett       Date:  2018-09-21       Impact factor: 2.967

Review 4.  Assessing resectability in cholangiocarcinoma.

Authors:  Tsuyoshi Sano; Yasuhiro Shimizu; Yoshiki Senda; Taira Kinoshita; Yuji Nimura
Journal:  Hepat Oncol       Date:  2013-12-20

5.  Endoscopic diagnosis of extrahepatic bile duct carcinoma: Advances and current limitations.

Authors:  Kiichi Tamada; Jun Ushio; Kentaro Sugano
Journal:  World J Clin Oncol       Date:  2011-05-10

Review 6.  Pathological diagnosis of flat epithelial lesions of the biliary tract with emphasis on biliary intraepithelial neoplasia.

Authors:  Yasunori Sato; Motoko Sasaki; Kenichi Harada; Shinichi Aishima; Toshio Fukusato; Hidenori Ojima; Yae Kanai; Masayoshi Kage; Yasuni Nakanuma; Hirohito Tsubouchi
Journal:  J Gastroenterol       Date:  2013-04-25       Impact factor: 7.527

7.  Histological characteristics of biliary intraepithelial neoplasia-3 and intraepithelial spread of cholangiocarcinoma.

Authors:  Yasunori Sato; Kenichi Harada; Motoko Sasaki; Yasuni Nakanuma
Journal:  Virchows Arch       Date:  2013-02-28       Impact factor: 4.064

8.  Perioperative blood transfusion as a poor prognostic factor after aggressive surgical resection for hilar cholangiocarcinoma.

Authors:  Norihisa Kimura; Yoshikazu Toyoki; Keinosuke Ishido; Daisuke Kudo; Yuta Yakoshi; Shinji Tsutsumi; Takuya Miura; Taiichi Wakiya; Kenichi Hakamada
Journal:  J Gastrointest Surg       Date:  2015-01-21       Impact factor: 3.452

Review 9.  Surgical management of carcinoma in situ at ductal resection margins in patients with extrahepatic cholangiocarcinoma.

Authors:  Toshifumi Wakai; Jun Sakata; Tomohiro Katada; Yuki Hirose; Daiki Soma; Pankaj Prasoon; Kohei Miura; Takashi Kobayashi
Journal:  Ann Gastroenterol Surg       Date:  2018-07-26

10.  Gamma-synuclein is a novel prognostic marker that promotes tumor cell migration in biliary tract carcinoma.

Authors:  Yusuke Takemura; Hidenori Ojima; Go Oshima; Masahiro Shinoda; Yasushi Hasegawa; Minoru Kitago; Hiroshi Yagi; Yuta Abe; Shutaro Hori; Yoko Fujii-Nishimura; Naoto Kubota; Yuki Masuda; Taizo Hibi; Michiie Sakamoto; Yuko Kitagawa
Journal:  Cancer Med       Date:  2021-07-09       Impact factor: 4.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.